Peer Review reports
From: A case of doxorubicin and cyclophosphamide therapy-induced type 1 diabetes: a case report
| Original Submission | ||
|---|---|---|
| 18 Aug 2022 | Submitted | Original manuscript |
| 18 Aug 2022 | Reviewed | Reviewer Report - Lokesh Goyal |
| 21 Aug 2022 | Reviewed | Reviewer Report - Taieb Ach |
| 26 Aug 2022 | Reviewed | Reviewer Report - Nipun de Silva |
| 27 Aug 2022 | Reviewed | Reviewer Report - Elvio Bueno |
| 30 Aug 2022 | Reviewed | Reviewer Report - ramesh gomez |
| 29 Sep 2022 | Author responded | Author comments - Makoto Miyabayashi |
| Resubmission - Version 2 | ||
| 29 Sep 2022 | Submitted | Manuscript version 2 |
| 15 Oct 2022 | Reviewed | Reviewer Report - Taieb Ach |
| 15 Oct 2022 | Reviewed | Reviewer Report - Nipun de Silva |
| 15 Oct 2022 | Reviewed | Reviewer Report - ramesh gomez |
| 17 Oct 2022 | Reviewed | Reviewer Report - Lokesh Goyal |
| 26 Oct 2022 | Author responded | Author comments - Makoto Miyabayashi |
| Resubmission - Version 3 | ||
| 26 Oct 2022 | Submitted | Manuscript version 3 |
| 2 Nov 2022 | Reviewed | Reviewer Report - Taieb Ach |
| 9 Nov 2022 | Reviewed | Reviewer Report - ramesh gomez |
| 10 Nov 2022 | Reviewed | Reviewer Report - Lokesh Goyal |
| 24 Nov 2022 | Reviewed | Reviewer Report - Nipun de Silva |
| 21 Dec 2022 | Author responded | Author comments - Makoto Miyabayashi |
| Resubmission - Version 4 | ||
| 21 Dec 2022 | Submitted | Manuscript version 4 |
| 28 Dec 2022 | Author responded | Author comments - Makoto Miyabayashi |
| Resubmission - Version 5 | ||
| 28 Dec 2022 | Submitted | Manuscript version 5 |
| 30 Dec 2022 | Author responded | Author comments - Makoto Miyabayashi |
| Resubmission - Version 6 | ||
| 30 Dec 2022 | Submitted | Manuscript version 6 |
| Publishing | ||
| 2 Jan 2023 | Editorially accepted | |
| 27 Jan 2023 | Article published | 10.1186/s13256-023-03755-x |
You can find further information about peer review here.